Showing results (51-60 of 369) with videos related to
Sort By:
Pageof 37
Journal of Affective Disorders|December 23, 2008
Medical and substance use comorbidity in bipolar disorderDavid E Kemp, Keming Gao, Stephen J Ganocy, et al.Neurosurgery|July 3, 2019
Clinical Evaluation of Cingulum Bundle Connectivity for Neurosurgical Hypothesis DevelopmentJennifer A Sweet, Sinem Balta Beylergil, Suraj Thyagaraj, et al.Psychopharmacology Bulletin|June 9, 2020
Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom SeverityKeming Gao, Jodi G Arnold, Thomas J Prihoda, et al.The Journal of Clinical Psychiatry|July 10, 2014
Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trialKeming Gao, Renrong Wu, David E Kemp, et al.Journal of Psychiatric Research|December 3, 2014
Disagreement between self-reported and clinician-ascertained suicidal ideation and its correlation with depression and anxiety severity in patients with major depressive disorder or bipolar disorderKeming Gao, Renrong Wu, Zuowei Wang, et al.Psychopharmacology Bulletin|January 18, 2011
Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot studyZuowei Wang, Keming Gao, David E Kemp, et al.Psychopharmacology Bulletin|October 15, 2016
A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety DisorderRanran Li, Renrong Wu, Jun Chen, et al.Expert Opinion on Drug Discovery|July 19, 2017
The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorderAwais Aftab, Keming GaoJournal of Clinical Psychopharmacology|August 27, 2011
A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depressionYiru Fang, Chengmei Yuan, Yifeng Xu, et al.The Journal of Clinical Psychiatry|July 1, 2008
Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trialsKeming Gao, Marcia L Verduin, David E Kemp, et al.Pageof 37